These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity. Kemp RA; Ronchese F J Immunol; 2001 Dec; 167(11):6497-502. PubMed ID: 11714817 [TBL] [Abstract][Full Text] [Related]
5. Adoptive immunotherapy of advanced tumors with CD62 L-selectin(low) tumor-sensitized T lymphocytes following ex vivo hyperexpansion. Wang LX; Chen BG; Plautz GE J Immunol; 2002 Sep; 169(6):3314-20. PubMed ID: 12218152 [TBL] [Abstract][Full Text] [Related]
6. Effective anti-tumor adoptive immunotherapy: utilization of exogenous IL-2-independent cytotoxic T lymphocyte clones. Iwashiro M; Jinyan W; Toda M; Linan W; Kato T; Kuribayashi K Int Immunol; 2002 Dec; 14(12):1459-68. PubMed ID: 12456594 [TBL] [Abstract][Full Text] [Related]
7. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy. Hu HM; Winter H; Urba WJ; Fox BA J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058 [TBL] [Abstract][Full Text] [Related]
8. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy. Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878 [TBL] [Abstract][Full Text] [Related]
9. Memory T cells originate from adoptively transferred effectors and reconstituting host cells after sequential lymphodepletion and adoptive immunotherapy. Wang LX; Kjaergaard J; Cohen PA; Shu S; Plautz GE J Immunol; 2004 Mar; 172(6):3462-8. PubMed ID: 15004146 [TBL] [Abstract][Full Text] [Related]
10. Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2. Roychowdhury S; May KF; Tzou KS; Lin T; Bhatt D; Freud AG; Guimond M; Ferketich AK; Liu Y; Caligiuri MA Cancer Res; 2004 Nov; 64(21):8062-7. PubMed ID: 15520217 [TBL] [Abstract][Full Text] [Related]
11. The dual role of IL-2 in the generation and maintenance of CD8+ memory T cells. Dai Z; Konieczny BT; Lakkis FG J Immunol; 2000 Sep; 165(6):3031-6. PubMed ID: 10975812 [TBL] [Abstract][Full Text] [Related]
12. Opposing effects of IL-2 in tumor immunotherapy: promoting CD8 T cell growth and inducing apoptosis. Shrikant P; Mescher MF J Immunol; 2002 Aug; 169(4):1753-9. PubMed ID: 12165496 [TBL] [Abstract][Full Text] [Related]
13. Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice. Contreras A; Sen S; Tatar AJ; Mahvi DA; Meyers JV; Srinand P; Suresh M; Cho CS Cancer Immunol Immunother; 2016 May; 65(5):601-11. PubMed ID: 27011014 [TBL] [Abstract][Full Text] [Related]
14. Expression of a tolerizing tumor antigen in peripheral tissue does not preclude recovery of high-affinity CD8+ T cells or CTL immunotherapy of tumors expressing the antigen. Ohlén C; Kalos M; Hong DJ; Shur AC; Greenberg PD J Immunol; 2001 Feb; 166(4):2863-70. PubMed ID: 11160355 [TBL] [Abstract][Full Text] [Related]
15. Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. Chakraborty M; Abrams SI; Camphausen K; Liu K; Scott T; Coleman CN; Hodge JW J Immunol; 2003 Jun; 170(12):6338-47. PubMed ID: 12794167 [TBL] [Abstract][Full Text] [Related]
17. Fate and function of anti-CD3/CD28-activated T cells following adoptive transfer: IL-2 promotes development of anti-tumor memory T cells in vivo. Hughes DP; Baskar D; Urban FF; Friedman MS; Braun TM; McDonagh KT Cytotherapy; 2005; 7(5):396-407. PubMed ID: 16236629 [TBL] [Abstract][Full Text] [Related]
18. TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag. Cottalorda A; Mercier BC; Mbitikon-Kobo FM; Arpin C; Teoh DY; McMichael A; Marvel J; Bonnefoy-Bérard N Eur J Immunol; 2009 Oct; 39(10):2673-81. PubMed ID: 19634192 [TBL] [Abstract][Full Text] [Related]
19. Ex vivo expansion of tumor specific lymphocytes with IL-15 and IL-21 for adoptive immunotherapy in melanoma. Huarte E; Fisher J; Turk MJ; Mellinger D; Foster C; Wolf B; Meehan KR; Fadul CE; Ernstoff MS Cancer Lett; 2009 Nov; 285(1):80-8. PubMed ID: 19501956 [TBL] [Abstract][Full Text] [Related]
20. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}. Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]